ClearPoint Neuro
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
120 S Sierra Ave Ste 100, Solana Beach, ...Phone Number
(888) 287-9109Website
www.clearpointneuro.comRevenue
$40.6 MillionStock Symbol
CLPTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About ClearPoint Neuro
ClearPoint Neuro Inc is a medical device company that specializes in developing and commercializing platforms for minimally invasive surgical procedures in the brain. The company provides navigation and delivery systems that enable precise targeting and real-time MRI guidance during neurosurgical interventions. ClearPoint Neuro's technology supports various therapeutic applications including deep brain stimulation, laser ablation, biopsy procedures, and drug delivery to treat neurological conditions. The company's solutions are designed to enhance surgical accuracy, improve patient outcomes, and expand treatment options for complex brain disorders. ClearPoint Neuro serves neurosurgeons and medical institutions seeking advanced tools for image-guided neurosurgery.Explore more
ClearPoint Neuro Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ClearPoint Neuro your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ClearPoint Neuro had a recent Job posting/layoffs
Check out if ClearPoint Neuro is spiking on competitors!
Funding: Get notified immidiatlly once ClearPoint Neuro has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ClearPoint Neuro, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at ClearPoint Neuro
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ClearPoint Neuro launches new products
Earning: See what the market has to say on ClearPoint Neuro recently announced quarterly report
Check if ClearPoint Neuro has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ClearPoint Neuro
Compare insights from companies similar to ClearPoint Neuro, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ClearPoint Neuro is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ClearPoint Neuro is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ClearPoint Neuro.
ClearPoint Neuro financials insights
Gather financial insights about ClearPoint Neuro, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Debt
$1.3M
2020
Debt
$350K
Debt
$7.5M
2021
Stock Offering
$43.4M
2025
Other Financing Round
$110M
2026
Private Equity
$17.9M
ClearPoint Neuro Tech Stack
A closer look at the technologies used by ClearPoint Neuro
Most Recent Scoops
Person-Based
Product Development, Corporate Strategy
Person-Based
Earnings, Finance
Person-Based
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Person-Based
Earnings, Acquisitions, Finance
ClearPoint Neuro News & Media
ClearPoint Neuro Q1 2026 Earnings Call Transcript
ClearPoint Neuro (NASDAQ:CLPT) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. View the webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=IjzOoM7l Summary ClearPoint Neuro reported record revenue of $12.1 million for Q1 2026, with a 43% growth rate driveWhat Creates a Long-Term Growth Opportunity for ClearPoint Neuro (CLPT)?
Minot Light Capital Partners, an investment management company, released its Q3 2025 investment letter. A copy of the letter can be downloaded here. In the quarter, Minot Light generated solid returns for limited partners, with a net of 7.6%. However, on a net basis, the performance underperformed the benchmarks, particularly the micro-cap benchmark’s 17.1% return. […]Here’s What Boosted ClearPoint Neuro (CLPT) in Q3
Deep Sail Capital, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here. The fund returned 5.8% net of fees in the third quarter, outperforming the Russell 2000 Mid Cap Growth Index’s 0.4% return and lagging the Russell 2000 Index’s 12.4% gain. YTD, the fund returned 18.1% […]ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsJoseph Burnett - President, CEO & DirectorDanilo...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ClearPoint Neuro
Sign Up For FreeTo access detailed company insights
ClearPoint Neuro Inc is a medical device company that specializes in developing and commercializing platforms for minimally invasive surgical procedures in the brain. The company provides navigation and delivery systems that enable precise targeting and real-time MRI guidance during neurosurgical interventions. ClearPoint Neuro's technology support... Read More
